1985
DOI: 10.1016/0091-6749(85)90726-2
|View full text |Cite
|
Sign up to set email alerts
|

Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex-mediated damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
0

Year Published

1985
1985
2020
2020

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 64 publications
(21 citation statements)
references
References 12 publications
1
20
0
Order By: Relevance
“…For instance, both deplete plasminogen within the thrombus, converting circulating plasminogen to plasmin [31]. Streptokinase is also immunogenic such that its use results in drug resistance, fever, and allergic reactions [20]. Second-generation agents such as t-PA and scu-PA are fibrin specific; however, they not only decrease the levels of circulating fibrinogen and plasminogen but also increase the risk of intracranial hemorrhage [19,28].…”
Section: Introductionmentioning
confidence: 99%
“…For instance, both deplete plasminogen within the thrombus, converting circulating plasminogen to plasmin [31]. Streptokinase is also immunogenic such that its use results in drug resistance, fever, and allergic reactions [20]. Second-generation agents such as t-PA and scu-PA are fibrin specific; however, they not only decrease the levels of circulating fibrinogen and plasminogen but also increase the risk of intracranial hemorrhage [19,28].…”
Section: Introductionmentioning
confidence: 99%
“…In most cases these symptoms develop 20 to 30 min after initiation of the streptokinase infusion [9]. However, McGrath et al [10] reported an allergic reaction to streptokinase 4 h after the first dose of streptokinase was finished and during the second one. In our patient the reaction was observed 3 h and 20 min after the start of the first dose and during the second infusion.…”
Section: Discussionmentioning
confidence: 99%
“…This therapy generates signi®-cant T-cell responses to SK (Bruserud et al, 1986(Bruserud et al, , 1992Bruserud, 1990;Youkeles et al, 1991) and causes Ab titers and the neutralizing capacity of the Ab to rise signi®cantly (Lynch et al, 1991(Lynch et al, , 1994Elliot et al, 1993;Lee et al, 1993;Patel et al, 1993;Parhami-Seren et al, 1995). The neutralizing Abs reduce the ef®ciency of thrombolytic therapy (Massel et al, 1991) and may cause allergic reactions ranging from fever to immune complex disease to anaphylactic shock (Davis et al, 1990;McGrath & Patterson, 1984;McGrath et al, 1985;Schweitzer et al, 1991).…”
Section: Introductionmentioning
confidence: 95%